Grindrod Shipping Holdings Ltd. GRIN 深 沪
已收盘 12-12 16:00:00 美东时间
27.5674
-0.328
-1.18%
华盛通- 最 高27.94
- 今 开27.91
- 成交量 7538股
- 最 低 27.46
- 昨 收 27.8953
- 总市值 5.43亿
- 52周最高 28.0252
- 市盈率 静 --
- 换手率 0.04%
- 52周最低 8.456
- 委 比 66.67%
- 总股本 1968.56万
- 历史最高 28.936
- 量 比 0.09
- 振 幅 1.72%
- 历史最低 1.981
- 每 手 1
- 风险率 0.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Grown Rogue Expands Ownership in Illinois Subsidiary to 100%
Grown Rogue International ( ($TSE:GRIN) ) just unveiled an update. Grown Rogue ...
09-22 19:46
Grown Rogue Expands Credit Facility to Boost Growth Initiatives
An announcement from Grown Rogue International ( ($TSE:GRIN) ) is now available...
09-15 19:57
单月超20亿美元，Biotech行业融资规模重返疫情前水平
转自：新康界 今年5月，美国及欧洲的生物医药行业共发生23起融资事件，融资规模达20.2亿美元（约143.03亿人民币），环比增幅达59.18%，其中值得关注的...
06-30 17:32
Victory Capital expands VictoryShares offerings with three new ETFs
Victory Capital Holdings (NASDAQ:VCTR) said on Thursday that its investment adviser, Victory Capital Management, has launched three new exchange-traded funds, VictoryShares Pioneer Asset-Based Income ...
06-26 20:45
Bio-Thera Solutions and Hikma Pharmaceuticals Announce FDA Approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) Injection
GUANGZHOU, China and LONDON, May 27, 2025 /PRNewswire/ -- Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovati...
05-27 14:00
Grown Rogue Strengthens Financial Position with Early Debenture Conversion
Grown Rogue International ( ($TSE:GRIN) ) has issued an update. Grown Rogue Int...
04-14 19:43
Grown Rogue Secures $7M Credit Facility to Boost Growth
Grown Rogue International ( ($TSE:GRIN) ) has provided an announcement. Grown R...
03-31 19:58
Grindwell Norton Announces Key Managerial Personnel Details
Grindwell Norton Limited ( ($IN:GRINDWELL) ) has shared an announcement. Grindw...
03-28 00:14
Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia
GUANGZHOU, China and HYDERABAD, India, March 27, 2025 /PRNewswire/ -- Bio-Thera Solutions (688177:SH; "Bio-Thera"), a commercial-stage biopharmaceutical company developing a pipeline of inno...
03-27 23:47
Grown Rogue Appoints New CFO Amidst Expansion Plans
Grown Rogue International (TSE:GRIN) has released an update. Grown Rogue Intern...
01-02 20:42
